–
Supernus Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
580
FY23:
524
FY24:
584
FY25:
644
(positive)
Change from FY21 to FY25
millions USD
FY21:
86.0
FY22:
46.1
FY23:
−5.27
FY24:
81.7
FY25:
−62.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
73.2
FY22:
60.7
FY23:
2.77
FY24:
97.9
FY25:
−49.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
53.4
FY22:
60.7
FY23:
1.32
FY24:
73.9
FY25:
−38.6
All amounts in millions USD